IMGS-001 is first dual-specific PD-L1/PD-L2 antibody with cytotoxic killing function and is designed to treat the many "immune-excluded" cancers that are ...

AI will deliver transformative therapies at an exponential scale, addressing the complexities of biology that traditional ...